A selective reversible monoamine oxidase B inhibitor in smoking cessation: Effects on its own and in association with transdermal nicotine patch

Psychopharmacology

Volumn 223, Issue 1, 2012, Pages 89-98

  Berlin, Ivan ^a   Hunneyball, Ian M ^b   Greiling, Doris ^c   Jones, Stephen P ^b   Fuder, Hermann ^c   Stahl, Hans Detlev ^d  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b EVOTEC UK LTD   (United Kingdom)

^c EVOTEC AG   (Germany)

^d ClinPharm International GmbH Prufzentrum Leipzig   (Germany)

Author keywords

Monoamine oxidase B inhibitor; Nicotine patch; Phase II clinical trial; Smoking cessation

Indexed keywords

COTININE; EVT 302; MONOAMINE OXIDASE B INHIBITOR; NICOTINE PATCH; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; APPENDICITIS; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; CONVULSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HUMAN; MALE; MONOTHERAPY; MULTICENTER STUDY; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; STREPTOCOCCUS PNEUMONIA; TREATMENT DURATION; TREATMENT RESPONSE; UNCONSCIOUSNESS;

ADULT; COTININE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE INHIBITORS; SALIVA; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84865137464     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2692-2     Document Type: Article

References (44)

1. Berlin I (2006) Monoamine oxidase inhibitors for smoking cessation. In: George TP (ed) Medication treatments for nicotine dependence. Taylor and Francis, New York, pp 109-121
2. Berlin I, Anthenelli RM (2001) Monoamine oxidases and tobacco smoking. Int J Neuropsychopharmacol 4:33-42 (Pubitemid 32390633)
3. Berlin I, Said S, Spreux-Varoquaux O, Olivares R, Launay J-M, Puech AJ (1995a) Monoamine oxidase A and B activities in heavy smokers. Biol Psychiatry 38:756-761
4. Berlin I, Saïd S, Spreux-Varoquaux O, Launay J-M, Olivares O, Millet V, Puech AJ (1995b) A reversible monoamine oxidase-A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers. Clin Pharmacol Therapeut 58:444-452
5. Berlin I, Aubin H-J, Pedarriosse A-M, Rames A, Lazabemide in Smoking Cessation Study Investigators, Lancrenon S, Lagrue G (2002) Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessation. Addiction 97:1347-1354
6. Biberman R, Neumann R, Kateir I, Gerber Y (2003) A randomized controlled trial of oral selegiline plus nicotine skin patch compared with placebo plus nicotine skin patch for smoking cessation. Addiction 98:1403-1407 (Pubitemid 37297247)
7. Cahill K, Stead LF, Lancaster T (2011) Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2:CD006103
8. Cappelleri JC, Bushmakin AG, Baker CL, Merikle E, Olufade AO, Gilbert DG (2007) Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire. Addict Behav 32:912-923 (Pubitemid 46282288)
9. Cox LS, Tiffany ST, Christen AG (2001) Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res 3:7-16 (Pubitemid 32611534)
10. Doll R, Peto R, Boreham J, Sutherland I (2004) Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 328(7455):1519
11. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, MacGregor R, Alexoff D, Shea C, Schlyer D, Wolf AP, Warner D, Zezulkova I, Cilento R (1996a) Inhibition of monoamine oxidase B in the brains of smokers. Nature 379:733-736 (Pubitemid 26061736)
12. Fowler JS, Volkow ND, Wang GJ, Pappas N, Logan J, Alexoff D, Shea C, MacGregor RR, Schlyer DJ, Zezulkova I, Wolf AP (1996b) Brain monoamine oxidase A inhibition in cigarette smokers. PNAS 93:14065-14069 (Pubitemid 26424246)
13. Fowler JS, Wang GJ, Volkow ND, Franceschi D, Logan J, Pappas N, Shea C, MacGregor RR, Garza V (2000) Maintenance of brain monoamine oxidase B inhibition in smokers after overnight cigarette abstinence. Am J Psychiatry 157:1864-1866
14. Fowler JS, Logan J, Wang GJ, Volkow ND, Telang F, Zhu W, Franceschi D, Pappas N, Ferrieri R, Shea C, Xu Y, Schlyer D, Gatley SJ, Ding YS, Alexoff D, Warner D, Netusil N, Carter P, Jayne M, King P, Vaska P (2003) Low monoamine oxidase B in peripheral organs. PNAS 100:11600-11605 (Pubitemid 37205982)
15. Fowler JS, Logan J, Wang GJ, Volkow ND, Telang F, Zhu W, Franceschi D, Shea C, Garza V, Xu Y, Ding YS, Alexoff D, Warner D, Netusil N, Carter P, Jayne M, King P, Vaska P (2005) Comparison of monoamine oxidase a in peripheral organs in nonsmokers and smokers. J Nucl Med 46:1414-1420 (Pubitemid 46173251)
16. George TP, O'Malley SS (2004) Current pharmacological treatments for nicotine dependence. Trends Pharmacol Sci 25:42-48 (Pubitemid 38081281)
17. George TP, Weinberger AH (2008) Monoamine oxidase inhibition for tobacco pharmacotherapy. Clin Pharmacol Ther 83:619-621 (Pubitemid 351417061)
18. George TP, Vessicchio JC, Termine A, Jatlow PI, Kosten TR, O'Malley SS (2003) A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation. Biol Psychiatry 53:136-143 (Pubitemid 36126476)
19. Gilbert DG, Zuo Y, Browning RA, Shaw TM, Rabinovich NE, Gilbert-Johnson AM, Plath L (2003) Platelet monoamine oxidase B activity changes across 31 days of smoking abstinence. Nicotine Tob Res 5:813-819 (Pubitemid 38029076)
20. Guillem K, Vouillac C, Azar MR, Parsons LH, Koob GF, Cador M, Stinus L (2005) Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats. J Neurosci 25:8593-8600 (Pubitemid 41362035)
21. Guillem K, Vouillac C, Azar MR, Parsons LH, Koob GF, Cador M, Stinus L (2006) Monoamine oxidase A rather than monoamine oxidase B inhibition increases nicotine reinforcement in rats. Eur J Neurosci 24:3532-3540 (Pubitemid 44952618)
22. Guillem K, Vouillac C, Koob GF, Cador M, Stinus L (2008) Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion. Biol Psychiatry 63:158-163 (Pubitemid 350299328)
23. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62
24. Hara S, Mukai T, Kurosaki K, Kuriiwa F, Endo T (2002) Modification of the striatal dopaminergic neuron system by carbon monoxide exposure in free-moving rats, as determined by in vivo brain microdialysis. Arch Toxicol 76:596-605
25. Hauptmann N, Shih JC (2001) 2-Naphtylamine, a compound found in cigarette smoke, decreases both monoamine oxidase A and B catalytic activity. Life Sci 68:1231-1241 (Pubitemid 32168027)
26. Herraiz T, Chaparro C (2005) Human monoamine oxidase is inhibited by tobacco smoke: beta-carboline alkaloids act as potent and reversible inhibitors. Biochem Biophys Res Commun 326:378-386 (Pubitemid 39593558)
27. Houtsmuller EJ, Thornton JA, Stitzer ML (2002) Effects of selegiline (l-deprenyl) during smoking and short-term abstinence. Psychopharmacology 163:213-220 (Pubitemid 35013613)
28. Hughes JR, Hatsukami D (1986) Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43:289-294 (Pubitemid 16052281)
29. Hughes, Jr., Stead L and Lancaster T (2007) Antidepressants for smoking cessation. Cochrane Database Syst Rev:CD000031
30. Khalil AA, Steyn S, Castagnoli N (2000) Isolation and characterization of monoamine oxidase inhibitor from tobacco leaves. Chem Res Toxicol 13:31-35 (Pubitemid 30055956)
31. Killen JD, Fortmann SP, Murphy GM Jr, Hayward C, Fong D, Lowenthal K, Bryson SW, Killen DT, Schatzberg AF (2010) Failure to improve cigarette smoking abstinence with transdermal selegiline+cognitive behavior thereapy. Addiction 105:1660-1668
32. Koob GF (2009) Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 56(Suppl 1):18-31
33. Lanteri C, Hernández Vallejo SJ, Salomon L, Doucet EL, Godeheu G, Torrens Y, Houades V, Tassin JP (2009) Inhibition of monoamine oxidases desensitizes 5-HT1A autoreceptors and allows nicotine to induce a neurochemical and behavioral sensitization. J Neurosci 29:987-997
34. Lewis A, Miller JH, Lea RA (2007) Monoamine oxidase and tobacco dependence. Neurotoxicology 28:182-195 (Pubitemid 46187252)
35. Méndez-Alvarez E, Soto-otero R, Sànchez-Sellero I, Lamas MLR (1997) Inhibition of brain monoamine oxidase by adducts of 1,2,3,4-tetrahydroisoquinoline with components of cigarette smoke. Life Sci 60:1719-1727 (Pubitemid 27210126)
36. Riederer P, Youdim MB (1986) Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl. J Neurochem 46:1359-1365 (Pubitemid 16062531)
37. Rose JE, Behm FM, Ramsey C, Ritchie JC (2001) Platelet monoamine oxidase, smoking cessation, and tobacco withdrawal symptoms. Nicotine Tob Res 3:383-390 (Pubitemid 33101065)
38. Stead LF, Perera R, Bullen C, Mant D, Lancaster T (2008) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 1:CD000146
39. Villégier A-S, Blanc G, Glowinski J, Tassin J-P (2003) Transient behavioral sensitization to nicotine becomes long-lasting with monoamine oxidase inhibitors. Pharmacol Biochem Behav 76:267-274 (Pubitemid 37329847)
40. Villégier AS, Salomon L, Granon S, Changeux JP, Belluzzi JD, Leslie FM, Tassin JP (2006) Monoamine oxidase inhibitors allow locomotor and rewarding responses to nicotine. Neuropsychopharmacology 31:1704-1713 (Pubitemid 44106701)
41. Weinberger AH, Reutenauer EL, Jatlow PI, O'Malley SS, Potenza MN, George TP (2010) A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers. Drug Alcohol Depend 107:188-195
42. WHO Report on the Global Tobacco Epidemic (2009) Implementing smoke-free environments. http://www.who.int/tobacco/mpower/2009/en/index.html. Accessed 11 March 2011
43. Wooters TE, Bardo MT (2007) The monoamine oxidase inhibitor phenelzine enhances the discriminative stimulus effect of nicotine in rats. Behav Pharmacol 18:601-608 (Pubitemid 47524886)
44. Yu PH, Boulton AA (1987) Irreversible inhibition of monoamine oxidase by some components of cigarette smoke. Life Sci 41:675-682 (Pubitemid 17100555)